butabarbital decreases consequences of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of CYP3A4 inducers might lower sufentanil ranges and efficacy, perhaps precipitating withdrawal syndrome in sufferers who have created Bodily dependence to sufentanil. Discontinuation of con